There is some really interesting stuff happening in the “reverse liver fibrosis” realm. Here is state of the art in 2009 (great review of the mechanism) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702953/ where we had no clear candidates, and Here is state of the art in 2015 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703795/ where we have literally hundreds of candidates (coffee and milk thistle (silymarin) […]
Category Archives: Blogs
Welcome to FixHepC, a trusted resource for those seeking effective and affordable solutions for Hepatitis C treatment. Our mission is to empower individuals with the knowledge and access to life-saving medications, ensuring that everyone has the opportunity to cure this condition. With expert guidance, patient testimonials, and up-to-date information on the latest treatments, we are here to support your journey toward a Hepatitis C-free life. Explore our resources, learn more about your treatment options, and take the first step toward a healthier future.
Our blog at FixHepC is dedicated to providing valuable insights, updates, and support for those affected by Hepatitis C. Here, you’ll find a wide range of topics, including the latest breakthroughs in Hepatitis C treatments, expert tips on managing the condition, and personal stories from individuals who have successfully undergone treatment. We also cover important health news, information on accessing affordable medications, and advice on navigating the healthcare system. Whether you’re newly diagnosed or exploring treatment options, our blog offers clear, reliable, and compassionate information to help you make informed decisions about your health.
21
Apr
Apr
Here is a copy of the generic hep c medication presentation given by Dr James Freeman at EASL 2017 today. Mostly the presentation followed the slides. The last words, with the last slide were “I want everyone to join the club, not the hep c buyers club, this club, the hep C cure club.” Click […]
14
Apr
Apr
“The Liver Meeting”, or AASLD 2011, was taking place at the great, glass-fronted Moscone West Convention Center in downtown San Francisco. Almost 9,000 people were there – family doctors, hepatologists, gastroenterologists, academics, drug salesmen, public health officials – all networking, trudging the escalators, wandering the beige exhibit halls, trying to stay on top of an […]
31
Mar
Mar
An article with the title: Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries just made it into the Lancet print edition: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32051-7/fulltext There is a PDF of it here
This article about the rationale for using generic hepatitis C medication has just been published in Liver International in their section "Debates in Hepatology". James A. D. Freeman1 and Andrew Hill2 1 GP2U Telehealth, Hobart, Tas., Australia 2 St Stephens AIDS Centre, Chelsea and Westminster Hospital, London, UK Liver Int. 2016; 36: 929–932. DOI: 10.1111/liv.13157 Abstract […]
According to a report on Tuesday, said Delaware State would embark on a new Medicaid policy program all in an attempt to treat hepatitis C patients. Added pressure will not be enough Ever since Obama Administration and lawsuits assumed office, most States are considered to be under pressure from the Delaware's case. For instance, Harvard […]
Приветствуем, всех, кто затронут вопросами хронических гепатитов, Мы рады представить некоммерческий проект «ГЕПАТИТКА», созданный группой активистов для поддержки, помощи и общения людей, затронутых вирусными гепатитами B, C и D. Начало этого проекта было положено в марте 2012 года пациентом из Москвы во время того, как он проходил курс лечения гепатита С пегилированнымиинтерферонами и рибавирином. Чтобы […]
In the world of Hepatitis C, the chances of getting the medical insurance to cover the high costs of your drugs comes down to a fibrosis score of an individual patient. In the US for example, Medicaid providers will in many cases cover the $94,500 Hepatitis C drug Harvoni costs only to the sickest patients, […]
So now it's common knowledge that the Indian patent office has approved Gilead's sofosbuvir patent but…. What Happened to the Indian Official that Rejected the US Drug Company Gilead’s Patent Application in 2015? It appears that being a man of honour is less valued than it should be. http://www.caravanmagazine.in/vantage/indian-official-rejected-gilead-patent-forced-out Hardev Karar, I salute you as […]